Healthtech Startups

Accupac is a contract development and manufacturing organization (CDMO) that provides formulation, manufacturing, and packaging services for beauty and personal care brands. It produces cosmetic, over-the-counter, and medical device products across skincare, haircare, oral care, and healthcare categories from cGMP, FDA-registered, and ISO-certified facilities.

3 investors

Accurx builds a communication platform that connects patients with healthcare professionals, supporting tasks like appointment booking, patient contact, referrals, video consultations, and health surveys. It serves NHS general practices and hospital trusts across the UK.

3 investors

Acrivon develops targeted precision oncology therapies matched to patients through its proteomics-based patient selection method, aiming to treat common solid cancers. Its pipeline includes clinical-stage kinase inhibitors for DNA Damage Response, cell cycle, and transcriptional regulator targets.

3 investors

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

3 investors

Tango Belt develops a wearable device that detects serious hip-impacting falls in older adults using fall-risk detection methodology. The product targets elderly populations to improve safety in everyday life.

3 investors

Actual Signal develops a smartphone-based platform that enables continuous monitoring of patients with neurological conditions, particularly Parkinson's disease, by capturing real-world data to help clinicians detect early changes and personalize treatments. The platform transforms traditional clinic visits into ongoing, data-driven patient care for healthcare organizations and care teams.

3 investors

Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions. It aims to support better health outcomes and clinical excellence for consumers.

3 investors

ADARx is a clinical-stage biotechnology company developing RNA-targeted therapeutics designed to control the expression of disease-driving genes. It focuses on treatments for a range of diseases with unmet medical needs.

3 investors

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.

3 investors

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier. It serves the oncology and cancer care market.

3 investors

Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s. The company targets people seeking weight management solutions beyond diet and calorie restriction.

3 investors

Adni operates a platform connecting healthcare workers with employment opportunities while providing tools for credential management and professional networking; the platform also serves healthcare employers seeking to identify and screen clinical talent through AI-powered recruiting capabilities.

3 investors

AdrenoMed AG is a clinical-stage biopharmaceutical company developing Enibarcimab (formerly Adrecizumab), a first-in-class antibody targeting the peptide Adrenomedullin to restore vascular integrity in critically ill patients, with septic shock as its lead indication. It applies a biomarker-guided precision medicine approach to identify patients most likely to benefit and is based in the Berlin area of Germany.

3 investors

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.

3 investors

Aegle Therapeutics develops therapies using extracellular vesicles (EVs) isolated from mesenchymal stem cells to deliver therapeutic biomolecules to diseased and damaged cells. Its lead product, AGLE-102, targets dystrophic epidermolysis bullosa, a rare pediatric skin-blistering disease, with potential applications across dermatology, immunology, and protein-deficiency disorders.

3 investors

AeroSafe Global provides cold chain logistics and pharmaceutical distribution solutions through its proprietary "Cold Chain as a Service" model, serving specialty distributors, pharmaceutical manufacturers, health systems, specialty pharmacies, and direct-to-patient programs worldwide. The company operates across 80 countries with real-time tracking and advanced packaging technology to ensure the safe delivery of temperature-sensitive therapies.

3 investors

Afilio provides digital estate planning and family care documentation services for German-speaking users. The platform enables families to organize advance directives, inheritance information, and emergency contacts in one secure, legally compliant location.

3 investors

After provides affordable and transparent end-of-life planning and funeral services for families, shifting control from funeral homes to consumers with customizable options.

3 investors

Agamon Health builds data platforms that transform clinical data into actionable insights for healthcare providers and institutions. The company serves doctors, hospitals, and the healthcare industry by simplifying medical reporting processes.

3 investors

CareInsights (formerly Agathos) is a mobile-first platform that delivers personalized peer-comparison insights on clinical metrics directly to physicians via text to drive improvements in care quality and reduce costs. The platform targets healthcare systems and physician leaders seeking to reduce clinical variation and improve patient outcomes.

3 investors

Agscent develops emissions monitoring and breath analysis systems for detecting greenhouse gases and biological markers. The company offers commercial-grade platforms for environmental monitoring and non-invasive diagnostic analysis across agricultural, animal health, and human health applications.

3 investors

Ahammune develops therapeutic treatments for chronic skin diseases with unmet medical need. The company aims to address dermatological disorders through scientific innovation and comprehensive treatment strategies.

3 investors

Kaia Health develops digital therapeutic programs for chronic pain management and COPD, serving enterprise companies, health plans, and health systems primarily in the US and Europe. The platform delivers clinically-guided exercise and mind-body therapy accessible via digital channels.

3 investors

AiCure develops H.Code, an AI platform using computer vision, chat, and predictive analytics to verify and monitor medication adherence and clinical behavior in trial participants via smartphone. It serves pharmaceutical companies, CROs, and healthcare providers across the clinical trial lifecycle.

3 investors